Showing results (101-110 of 163) with videos related to
Sort By:
Pageof 17
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 4, 2020
Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinomaChen Yang, Robert S Cimera, Ruth Aryeequaye, et al.The American Journal of Surgical Pathology|August 2, 2007
Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrumPedram Argani, Semra Olgac, Satish K Tickoo, et al.The American Journal of Surgical Pathology|May 21, 2019
In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical RecurrenceYujiro Ito, Emily A Vertosick, Daniel D Sjoberg, et al.Histopathology|May 3, 2022
An introduction to the WHO 5th edition 2022 classification of testicular tumoursDaniel M Berney, Ian Cree, Vishal Rao, et al.Cancers|December 11, 2025
Clinical and Molecular Characterization of KRAS-Mutated Renal Cell CarcinomaAndrea Lopez Sanmiguel, Yash S Khandwala, Kuo Fengshen, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 24, 2021
Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcomePaari Murugan, Liwei Jia, Renzo G Dinatale, et al.The American Journal of Surgical Pathology|January 21, 2014
Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistryYing-Bei Chen, A Rose Brannon, Antoun Toubaji, et al.BJU International|June 23, 2021
Clinical utility of subclassifying positive surgical margins at radical prostatectomyShawn Dason, Emily A Vertosick, Kazuma Udo, et al.The American Journal of Surgical Pathology|July 16, 2014
Best practices recommendations in the application of immunohistochemistry in urologic pathology: report from the International Society of Urological Pathology consensus conferenceMahul B Amin, Jonathan I Epstein, Thomas M Ulbright, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2013
Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research networkA Ari Hakimi, Irina Ostrovnaya, Boris Reva, et al.Pageof 17